AstraZeneca plans $360 million Irish manufacturing investment
LONDON, UK: AstraZeneca is planning on establishing a next-generation active pharmaceutical ingredient (API) manufacturing facility for small molecules near Dublin, Ireland to ensure the Company’s global supply network is fit for future growth, a bourse filing said. The new plant…